Collectively, these results demonstrated Smac mimetic SM-164 significantly potentiates APO2L/TRAIL-mediated anticancer activity in HCC cells with minimal toxicity on human normal liver cells. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.